Visual reinforcement audiometry and its association with neonatal hearing screening and the offer of speech therapists, services and equipment.
Monique Ramos Paschoal Dutra, Rodrigo Oliveira da Fonsêca, Aryelly Dayane da Silva Nunes-Araújo and 1 others
PMID 41637259WHAT IT FOUND
More neonatal hearing screenings do not lead to more visual reinforcement audiometry (VRA) for infants.
VRA rates fell sharply after 2009, and states with more speech therapists or equipment did not perform the test more often.
Key findings
01No significant correlation was found between VRA performance rates and neonatal hearing screening rates, speech therapist availability, hearing health services, or VRA equipment.
02VRA rates peaked between 2007 and 2009 and then declined significantly in subsequent periods.
03States with high neonatal hearing screening coverage often conducted fewer VRA tests, indicating a gap in follow-up diagnosis.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study used state-level data, so it cannot explain individual patient reasons for missing appointments or specific local barriers. The health information systems used may have underreported or missed data, and the records did not specify the age at which VRA was performed, making it hard to confirm if the test was used for the correct age group (5-24 months). The analysis did not account for children who might have accessed private healthcare, potentially skewing the public system rates.
Declared interests
The authors declared no financial support and no conflicts of interest.
The easy way to misread this
Do not assume that hiring more speech therapists or buying more VRA equipment will automatically increase the number of children diagnosed. The study found no correlation between these resources and VRA rates, suggesting that other factors, such as referral pathways or clinical protocols, are the primary bottlenecks.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →